Ubrogepant (Compound)

Synonyms:Ubrogepant, 1374248-77-7, Ubrelvy, MK-1602, Ubrogepant anhydrous, UNII-AD0O8X2QJR, AD0O8X2QJR, DTXSID00160178, MK1602, (3S)-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl]-2-oxospiro[1H-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide

Pubchem:PUBCHEM:68748835

Id:d08b0563-7ce3-5d59-974f-708c7e81b95c

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Ubrogepant's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Ubrogepant.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Ubrogepant.

Results found

Linked to

	Label	Description
	Ubrogepant indication Migraine Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	ubrogepant (00605e76-eecb-4d9d-8f9d-ef770e17a323) Collection (Entity type)	Metadatata for ubrogepant
	DCSTRUCT ID 05361 Collection (Entity type)	DrugPage Collection: (DrugCentralID:05361; PubChem_CID:68748835, FILE=drugcentral_drug_05361.json)

Ubrogepant indication Migraine Disorders

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

ubrogepant (00605e76-eecb-4d9d-8f9d-ef770e17a323)

Collection (Entity type)

Metadatata for ubrogepant

DCSTRUCT ID 05361

Collection (Entity type)

DrugPage Collection: (DrugCentralID:05361; PubChem_CID:68748835, FILE=drugcentral_drug_05361.json)

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.